Scientific progress in oncology is steadily presenting new perspectives for patients with thoracic malignancies, including targeted drugs and multimodality therapy. In this book, leading experts provide us with the current standard-of-care and new treatment approaches for patients with lung cancer, mesothelioma and thymoma.